Tadalafil for Prevention of Erectile Dysfunction After Radiotherapy for Prostate Cancer | Zendy

Thomas M. Pisansky | Zendy; Stephanie L. Pugh | Zendy; Richard E. Greenberg | Zendy; Nadeem Pervez | Zendy; Daniel R. Reed | Zendy; Seth A. Rosenthal | Zendy; Rex B. Mowat | Zendy; Adam Raben | Zendy; Mark K. Buyyounouski | Zendy; Lisa A. Kachnic | Zendy; Deborah Watkins Bruner | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tadalafil for Prevention of Erectile Dysfunction After Radiotherapy for Prostate Cancer

Author(s) -

Thomas M. Pisansky,

Stephanie L. Pugh,

Richard E. Greenberg,

Nadeem Pervez,

Daniel R. Reed,

Seth A. Rosenthal,

Rex B. Mowat,

Adam Raben,

Mark K. Buyyounouski,

Lisa A. Kachnic,

Deborah Watkins Bruner

Publication year - 2014

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2014.2626

Subject(s) - tadalafil , medicine , prostate cancer , erectile dysfunction , radiation therapy , sexual function , placebo , brachytherapy , randomization , adverse effect , urology , external beam radiotherapy , gynecology , randomized controlled trial , cancer , alternative medicine , pathology

Tadalafil is used to treat erectile dysfunction after prostate cancer treatment, but its role as a preventive agent is undefined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research